Protara Therapeutics reports positive six-month ADVANCED-2 trial data for TARA-002 and plans 2025 milestones for ongoing trials. Protara Therapeutics, Inc. announced positive six-month findings from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback